1226395
1226695
1226747
1226694
Image of scientist holding up a Petri dish
Supporting Excellence
The Wellcome Centre for Infectious Diseases Research in Africa fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1 and tuberculosis, through clinical and laboratory research.
Macrophages infected with M. tuberculosis; image by Dr Suraj Parihar
Basic Science
Our Basic Science Platform provides the laboratory infrastructure and technical support to ensure the safe handling of infectious material.
Subgraph of the ANIMA network for dataset HIVsetB
Biomedical Data Integration
We work with multidimensional clinical and scientific data at the molecular, cellular, clinical and population levels.
Image of a researcher and study participant reading an informed consent document
Clinical Research
CIDRI-Africa supports clinical studies in the community at our facility at Site B in Khayelitsha.

News

Monday, 22 April 2019
Icon made from <a href="http://www.onlinewebfonts.com/icon">Icon Fonts</a> is licensed by CC BY 3.0
TB meningitis clinical trial stakeholder engagement

Community stakeholders representing various Khayelitsha-based organisations gathered to consult with CIDRI-Africa’s clinical research team on future tuberculous meningitis research. 

Publication Date:
Thu, 15 Nov 2018 - 11:45
Prednisone molecular structure
Prednisone reduces risk of TB-IRIS during antiretroviral treatment, shows CIDRI-Africa team

The PredART study—published in the New England Journal of Medicine—showed that a four-week course of moderate dose prednisone reduced the risk of TB-IRIS by 30% in HIV-positive patients at high risk.

Publication Date:
Thu, 15 Nov 2018 - 08:00
EDCTP Senior Fellowship awarded to CIDRI-Africa Contributing Investigator Associate Professor Maia Lesosky

Maia will develop novel statistical methods for analysis of complex study data on lung health in Africa.

Publication Date:
Wed, 14 Nov 2018 - 14:00
Image of syringe and needle; via Pixabay
Union Scientific Director comments on M72 vaccine trial

Following the recent International Union against Tuberculosis and Lung Disease World Conference, Scientific Director Dr Paula Fujiwara commented on several new TB-related innovations, including the M72 vaccine trial in which CIDRI-Africa participated.

Publication Date:
Mon, 29 Oct 2018 - 08:30

Pages

TOP